| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $41,859,837 ) (Continued on the next page) |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA262393 | Targeted Prevention of Postpartum-Related Breast Cancer (PRBC) | 000 | 3 | NIH | 2/23/2024 | $584,952 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01GM144393 | Exploiting new approaches for selective inhibition of trypsins | 001 | 3 | NIH | 6/12/2024 | $29,078 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01GM144393 | Exploiting new approaches for selective inhibition of trypsins | 000 | 3 | NIH | 11/8/2023 | $261,703 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01NS121125 | Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight | 000 | 4 | NIH | 4/29/2024 | $780,935 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG067763 | Molecular characterization of extracellular vesicles for the spread of misfolded tau protein | 000 | 4 | NIH | 4/26/2024 | $611,392 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U19AG069701 | Biology and pathobiology of apoE in aging and Alzheimer's disease | 001 | 4 | NIH | 7/15/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U19AG069701 | Biology and pathobiology of apoE in aging and Alzheimer's disease | 000 | 4 | NIH | 6/5/2024 | $6,474,838 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA258274 | Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy | 001 | 4 | NIH | 4/18/2024 | $16,126 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA258274 | Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy | 000 | 4 | NIH | 2/12/2024 | $290,242 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R37CA248298 | Role of Sirt2 in T Cell Metabolism | 002 | 5 | NIH | 4/18/2024 | $17,901 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R37CA248298 | Role of Sirt2 in T Cell Metabolism | 001 | 5 | NIH | 2/15/2024 | $322,194 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA239726 | A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma | 001 | 4 | NIH | 6/17/2024 | $340,095 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA237602 | Involution-based biomarkers of breast cancer risk | 001 | 5 | NIH | 5/2/2024 | $141,218 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA237602 | Involution-based biomarkers of breast cancer risk | 000 | 5 | NIH | 5/1/2024 | $473,716 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01NS118513 | Targeting Go and Grow in Glioblastoma | 000 | 5 | NIH | 7/12/2024 | $534,339 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG072719 | Assessment of a novel tau propagation pathway from layer II medial entorhinal cortical neurons to CA1 pyramidal neurons as an early Braak stage mouse model | 000 | 4 | NIH | 4/26/2024 | $532,892 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG065219 | Impact of T cells on the CNS during aging and Alzheimer’s disease | 000 | 5 | NIH | 4/18/2024 | $485,150 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG063780 | Mechanistic insights into the link between the A152T risk variant and tauopathy | 000 | 5 | NIH | 4/18/2024 | $402,502 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG066429 | Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's disease | 001 | 5 | NIH | 6/28/2024 | $39,125 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG066429 | Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's disease | 000 | 5 | NIH | 3/22/2024 | $352,125 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | K01CA237875 | Integrated molecular epidemiologic analysis of the one-carbon metabolism pathway and risk of HCC | 000 | 5 | NIH | 3/18/2024 | $150,656 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK117910 | Mechanisms of Hereditary Pancreatitis | 001 | 5 | NIH | 2/8/2024 | $685,854 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01HL140411 | Distinct Pathways of VPF/VEGF Receptors | 000 | 5 | NIH | 3/13/2024 | $667,504 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK139207 | Deciphering Pancreatitis Microenvironment through Intravital Imaging | 000 | 1 | NIH | 3/27/2024 | $578,659 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | P01NS084974 | Pathobiology of Neurodegeneration in C9ORF72 repeat expansion | 001 | 10 | NIH | 5/14/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | P01NS084974 | Pathobiology of Neurodegeneration in C9ORF72 repeat expansion | 000 | 10 | NIH | 4/11/2024 | $2,581,235 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01HG011461 | PaSAGE: PAtient Supported Approaches to Gene Editing | 001 | 3 | NIH | 7/17/2024 | $210,041 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01HG011461 | PaSAGE: PAtient Supported Approaches to Gene Editing | 000 | 3 | NIH | 7/16/2024 | $809,447 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01NS129671 | Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma | 001 | 2 | NIH | 4/16/2024 | $43,286 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01NS129671 | Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma | 000 | 2 | NIH | 12/8/2023 | $556,542 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG075802 | Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | 001 | 3 | NIH | 5/2/2024 | $308,010 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG075802 | Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | 000 | 3 | NIH | 11/7/2023 | $2,772,090 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | F30AG085984 | The Role of TMEM106B in FTLD-TDP Pathogenesis | 002 | 1 | NIH | 4/30/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | F30AG085984 | The Role of TMEM106B in FTLD-TDP Pathogenesis | 001 | 1 | NIH | 4/30/2024 | $1,280 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | F30AG085984 | The Role of TMEM106B in FTLD-TDP Pathogenesis | 000 | 1 | NIH | 12/6/2023 | $47,894 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R35NS097273 | Expanding insights into FTD disease mechanisms | 001 | 8 | NIH | 2/7/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R35NS097273 | Expanding insights into FTD disease mechanisms | 000 | 8 | NIH | 11/24/2023 | $985,949 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG054199 | APOE and microglia-mediated progression in tau pathology in AD | 000 | 3 | NIH | 7/12/2024 | $727,596 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG066395 | TREM2-mediated microglial dynamic function in Alzheimer disease | 001 | 5 | NIH | 6/4/2024 | $74,211 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG066395 | TREM2-mediated microglial dynamic function in Alzheimer disease | 000 | 5 | NIH | 12/14/2023 | $667,901 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R21CA284153 | Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistance | 001 | 1 | NIH | 7/12/2024 | $0 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R21CA284153 | Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistance | 000 | 1 | NIH | 7/8/2024 | $402,401 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG087165 | Elucidating the Pathomechanisms of APOE4 in Lewy Body Dementia | 000 | 1 | NIH | 6/25/2024 | $777,126 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01HL164520 | Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex | 000 | 3 | NIH | 6/27/2024 | $710,444 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01HL164520 | Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex | 001 | 3 | NIH | 7/1/2024 | $24,414 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK139604 | Protein Kinase D1 as a switch from acute to chronic pancreatitis | 000 | 1 | NIH | 3/1/2024 | $340,388 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01EB035231 | Deep learning for opportunistic screening for osteoporosis and osteopenia from radiographs | 001 | 1 | NIH | 6/6/2024 | $87,037 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01EB035231 | Deep learning for opportunistic screening for osteoporosis and osteopenia from radiographs | 000 | 1 | NIH | 3/13/2024 | $304,632 |
| 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG071226 | Endothelial cell senescence and APOE4 in vascular cognitive impairment and dementia | 001 | 2 | NIH | 7/16/2024 | $39,125 |
|